GSK-2838232

CAS No. 1443460-91-0

GSK-2838232 ( GSK2838232 )

Catalog No. M11882 CAS No. 1443460-91-0

GSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 125 Get Quote
10MG 200 Get Quote
25MG 439 Get Quote
50MG 641 Get Quote
100MG 888 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK-2838232
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.
  • Description
    GSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.HIV Infection Phase 2 Clinical
  • Synonyms
    GSK2838232
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    Infection
  • Indication
    HIV Infection

Chemical Information

  • CAS Number
    1443460-91-0
  • Formula Weight
    809.57
  • Molecular Formula
    C48H73ClN2O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 50 mg/mL 61.76 mM
  • SMILES
    O=C(O)C(C)(C)CC(O[C@@H](CC[C@]1(C)[C@@]2([H])CC[C@@]34[H])C(C)(C)[C@]1([H])CC[C@@]2(C)[C@]3(C)CC[C@]5([C@@H](O)CN(CC6=CC=CC(Cl)=C6)CCN(C)C)C4=C(C(C)C)C(C5)=O)=O
  • Chemical Name
    (3b)-3-(3-Carboxy-3-methyl-1-oxobutoxy)-17-[(1R)-2-[[(4-chlorophenyl)methyl][2-(dimethylamino)ethyl]amino]-1-hydroxyethyl]-28-norlup-18-en-21-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Atazanavir sulfate

    A highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture.

  • ALW-II-41-27

    ALW-II-41-27, an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.

  • BMS-818251

    BMS-818251 (BMS818251) is a novel potent, small-molecule inhibitor of HIV-1 entry with EC50 of 0.019 nM against e laboratory-adapted HIV-1 strain NL4-3.